Commentary on Astrachan et al. The transmutation of research risk in pragmatic clinical trials

Abstract

Get full access to this article

View all access options for this article.

References

Astrachan

Flory

Kim

SYH

. Individualized clinical decisions within standard-of-care pragmatic clinical trials: implications for consent. Clin Trials, in press.

Kane

Kim

SYH

Kimmelman

. What research ethics (often) gets wrong about minimal risk. Am J Bioeth 2020; 20(1): 42–44.

Hsee

. The evaluability hypothesis: an explanation for preference reversals between joint and separate evaluations of alternatives. Organ Behav Hum Decis Process 1996; 67: 247–257.

Fischhoff

Watson

Hope

. Defining risk. Policy Sci 1984; 17: 123–139.